2024 Editorial Calendar

Content themes:

• Bio/Pharma’s Top 10: Monthly tracker of the top 10 trends, deals, and developments impacting global bio/pharmaceutical industry performance and the global bio/pharmaceutical manufacturing value chain.
• The CDMO/CMO and Suppliers Report: The keys developments from CDMOs/CMOs and suppliers and trends shaping bio/pharmaceutical outsourcing and supply.
• What’s Trending: The people, companies and trends shaping bio/pharmaceutical drug development, commercialization, manufacturing and the supply lines.
• Manufacturing and Supply Lines: The latest developments impacting the bio/pharmaceutical manufacturing value chain, from raw materials to active pharmaceutical ingredients (small molecules and biologics) to drug products to packaging.
• Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.

Editorial Questions? Contact Patricia Van Arnum, DCAT’s Editorial Director at pvanarnum@dcat.org, Tel: +1-(856)-388-2964

DCAT Value Chain Insights 2024 Editorial Calendar: January-December 2024

January 5	Bio/Pharma’s Top 10: An Industry Watchlist for 2024 The top 10 issues to be on the look for in 2024.
January 12	CDMO/CMO and Suppliers Report: The Year Ahead in Pharma Outsourcing An outlook for bio/pharmaceutical outsourcing for 2024.
January 19	What’s Trending: Emerging Trends on the Industry’s Radar The issues emerging on the industry’s radar for 2024.
January 26	Manufacturing and Supply Lines: The Impact Factors for 2024 Perspectives on the key issues impacting bio/pharma manufacturing and supply in 2024.

February 2	Bio/Pharma’s Top 10: New Drug Approvals Top 10 trends in new drug approvals, including the mix between small molecules and biologics.
February 9	The CDMO/CMO and Suppliers Report: Small-Molecule APIs A roundup of expansions in small-molecule active pharmaceutical ingredient (API) and intermediates development and manufacturing.
February 16	What’s Trending: Parenteral Drugs Key trends in parenteral drugs, including in new drug approvals.
February 24	Special Report: DCAT Week 2024 Preview Special preview of upcoming speakers and education programs at DCAT Week 2024 (March 18 to March 21, 2024).

March 1	Special Report: DCAT Week 2024 Preview Special preview of upcoming speakers and education programs at DCAT Week 2024 (March 18 to March 21, 2024).
March 8	No issue DCAT Week 2024 (March 18 to March 21, 2024).
March 15	No issue DCAT Week 2024 (March 18 to March 21, 2024).
March 22	No issue DCAT Week 2024 (March 18 to March 21, 2024).
March 29	Special Report: DCAT Week 2024 in Review Detailed roundup from the DCAT Member Company Announcement Forum and the DCAT Research & Benchmarking Study as presented at DCAT Week 2024.

April 5	Special Report: DCAT Week 2024 in Review Detailed roundup from the education programs as presented at DCAT Week 2024.
April 12	The CDMO/CMO and Suppliers Report: Biomanufacturing Latest roundup of expansion activity among CDMOs/CMOs in biomanufacturing.
April 19	What’s Trending: Generic Drugs Market overview and key trends driving the generic-drug market.
April 26	Manufacturing and Supply Lines: Small-Molecule APIs Market overview for small-molecule active pharmaceutical ingredients (APIs) and supply–demand fundamentals.

May 3	Bio/Pharma’s Top 10: Blockbuster Watchlist A look at the top 10 drugs slated for launch in 2024 with blockbuster potential over the next five years.
May 10	The CDMO/CMO and Suppliers Report: Injectable Drugs Roundup of expansions by CDMO/CMOs for injectable drugs.
May 17	What’s Trending: Bio/Pharma Outsourcing The key trends and developments in the CDMO/CMO sector.
May 24	No issue
May 31	Manufacturing and Supply Lines: Continuous Manufacturing Update of key projects, investments, and advances in continuous manufacturing/ and flow chemistry.

June 7	Bio/Pharma’s Top 10: API Sourcing Key trends/issues impacting sourcing for small-molecule active pharmaceutical ingredients (APIs) and intermediates.
June 14	The CDMO/CMO and Suppliers Report: Peptides & Oligonucleotides A roundup of the latest expansions among CDMOs/CMOs for peptides and oliogonucleotides and key market trends.
June 21	What’s Trending: Distributors Market overview and key trends impacting global supply chains for distributors of chemicals and pharma ingredients.
June 28	Manufacturing and Supply Lines: Inside Big Pharma’s Manufacturing Networks The latest manufacturing expansion activity among the bio/pharmaceutical majors.

July 5	No issue
July 12	The CDMO/CMO and Suppliers Report: High-Potency APIs Update on expansions by CDMOs/CMOs for high-potency active pharmaceutical ingredients (HPAPI) manufacturing and related trends.
July 19	What’s Trending: Mid-Year Review—New Drug Approvals Update on new drug approvals thus far in 2024 and related trends.
July 26	Manufacturing and Supply Lines: Chemicals & Raw Materials The latest on the trends and issues impacting chemicals supply and raw materials sourcing.

August 2	Bio/Pharma’s Top 10: Top Mergers & Acqusitions Thus Far in 2024 Analysis of top 10 mergers and acquisitions among bio/pharma companies thus far in 2024.
August 9	The CDMO/CMO and Suppliers Report: Packaging Industry overview of key trends and developments in primary and secondary packaging.
August 16	What’s Trending: Excipients Latest market data and trends for exciepients, including initiatives for faciliating regulatory pathways for novel excipients.
August 23	Manufacturing and Supply Lines: Cell & Gene Therapies Update of key expansions for manufacturing of cell and gene therapies.
August 30	No issue

September 6	Bio/Pharma’s Top 10: Biologics The top 10-selling biologics and pipeline contenders.
September 13	The CDMO/CMO and Suppliers Report: Solid Dosage Drug Products Latest developments by CDMOs/CMO in solid-dosage development and manufacturing, including strategies for bioavailability enhancement.
September 20	What’s Trending: Big Pharma Partnering Deals with Emerging Pharma Key partnering deals and related trends between Emerging Pharma companies and the large bio/pharma companies.
September 27	Manufacturing and Supply Lines: Green Chemistry Latest on key technological developments in small-molecule actove pharmaceutical manufacturing, including green chemistry.

October 4	Bio/Pharma’s Top 10: The Top Small-Molecule Drugs The top 10-selling small molecules and pipeline contenders.
October 11	The CDMO/CMO and Suppliers Report: Biomanufacturing A roundup of key expansions by CDMOs/CMOs in biomanufacturing.
October 18	What’s Trending: Drug Delivery and Drug Products Key developments and trends in drug delivery and drug-product development and manufacturing.
October 25	Manufacturing and Supply Lines: mRNA Manufacturing Roundup of latest expansion in mRNA development and manfuacturing for mRNA therapeutics and vaccines.

November 1	Bio/Pharma’s Top 10: The Pipeline Contenders Top 10 late-stage drug candidates with strong market potential.
November 8	The CDMO/CMO and Suppliers Report: High-Potency Drug Products A roundup of expansions of CDMOs/CMOs in high-potency drug-product development and manufacturing.
November 15	What’s Trending: The Rising Stars Companies and executives making the moves in 2024.
November 22	Manufacturing and Supply Lines: Small-Molecue APIs Key developments impacting the supply of small-molecule active pharmaceutical ingredients.
November 29	No issue

December 6	Bio/Pharma’s Top 10: The Year in Review A look at the top 10 developments in the bio/pharma industry in 2024.
December 13	The CDMO/CMO and Suppliers Report: The Movers and Shakers of 2024 A look at the top expansions and mergers/acquisitions from CDMOs/CMOs in 2024.
December 20	No issue.
December 27	No issue.